The objective of this P01 is to elucidate the biological function(s) of proteins that play important roles in controlling breast development and breast carcinogenesis, through the development and availability of high-throughput protein expression methodologies. In Core A, our immediate goal is to complete and distribute a ready-to-use repository of clones for 1000 full-length cDNAs (fusion and closed reading frames) for genes associated with breast development and breast carcinogenesis. This effort, known as the Breast Cancer 1000 Project (BC1000), exploits recombinational cloning technology that allows DNA fragments to be moved easily from one vector to another. The initial selection of BC1000 genes was primarily determined by the P01 members with the intent of providing the most useful resource to this research community. Monthly meetings with the P01 members continue to provide direction for this project which, in the longer term, will produce a useful resource to the larger community of breast cancer researchers. All resources generated by this project will be accessible to members of the P01 and the broader biomedical research community. The work in this core is divided into two general components: to provide core services and to develop technology for facilitating functional assays using the BC1000 collection. The core services will include the completion and distribution of the BC1000 genes to the members of this grant and the breast cancer research community. These clones will be in a ready-to-use format and the relevant information on these clones will be easily accessible in a public database (Specific Aim 1). To complement these core services, we will develop the technology needed to facilitate functional experimentation using the BC1000. This will include the modification of useful expression vectors and development of automated methods for high-throughput transfer of these clones to these vectors for use in functional or genetic screens (Specific Aim 2). We will also develop and maintain a database to track completed clones and results of experiments done with the BC1000 (Specific Aim 3). This database will provide P01 members a central location to query for available clone information and to stimulate new research ideas from the existing experimental results.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA080111-08
Application #
7221174
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-02-01
Budget End
2007-01-31
Support Year
8
Fiscal Year
2006
Total Cost
$152,519
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
120989983
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Xiao, Tengfei; Li, Wei; Wang, Xiaoqing et al. (2018) Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy. Proc Natl Acad Sci U S A 115:7869-7878
Zhang, Jinfang; Bu, Xia; Wang, Haizhen et al. (2018) Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature 553:91-95
Li, Andrew G; Murphy, Elizabeth C; Culhane, Aedin C et al. (2018) BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1? activation. Proc Natl Acad Sci U S A 115:E9600-E9609
Wu, Yanming; Zhang, Zhao; Cenciarini, Mauro E et al. (2018) Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ER?-GREB1 Transcriptional Axis. Cancer Res 78:671-684
Witwicki, Robert M; Ekram, Muhammad B; Qiu, Xintao et al. (2018) TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer. Cell Rep 25:1255-1267.e5
Jeselsohn, Rinath; Bergholz, Johann S; Pun, Matthew et al. (2018) Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations. Cancer Cell 33:173-186.e5
Hinohara, Kunihiko; Wu, Hua-Jun; Vigneau, Sébastien et al. (2018) KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance. Cancer Cell 34:939-953.e9
Wan, Lixin; Xu, Kexin; Wei, Yongkun et al. (2018) Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function. Mol Cell 69:279-291.e5
Tavera-Mendoza, Luz E; Westerling, Thomas; Libby, Eric et al. (2017) Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells. Proc Natl Acad Sci U S A 114:E2186-E2194
Dreijerink, Koen M A; Groner, Anna C; Vos, Erica S M et al. (2017) Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer. Cell Rep 18:2359-2372

Showing the most recent 10 out of 136 publications